Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Alimta
Pharma
Eagle's Pemfexy catches up with Lilly's Alimta in lung cancer
The FDA has blessed Eagle's Pemfexy with a fifth NSCLC indication, this one in combo with Merck’s Keytruda and platinum chemotherapy.
Kevin Dunleavy
Dec 19, 2022 10:25am
The top 10 drugs losing US exclusivity in 2022
Mar 8, 2022 3:00am
FDA sets countdown to Lilly, Innovent's PD-1. What to expect?
May 18, 2021 10:20am
Sanofi, AZ, Lilly and more win in China's expanded purchase bid
Sep 25, 2019 11:02am
Pfizer, Merck topped the Dow in 2018 despite biopharma declines
Jan 2, 2019 11:33am
Merck extends lung-cancer lead with Keytruda combo win
Jan 16, 2018 11:38am
